This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. MDXG, PGEN, RAPP, TNGX, MNMD, BGM, EYPT, OCS, ANAB, and FTREShould you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include MiMedx Group (MDXG), Precigen (PGEN), Rapport Therapeutics (RAPP), Tango Therapeutics (TNGX), Mind Medicine (MindMed) (MNMD), BGM Group (BGM), Eyepoint Pharmaceuticals (EYPT), Oculis (OCS), AnaptysBio (ANAB), and Fortrea (FTRE). These companies are all part of the "med - biomed/gene" industry. Third Harmonic Bio vs. Its Competitors MiMedx Group Precigen Rapport Therapeutics Tango Therapeutics Mind Medicine (MindMed) BGM Group Eyepoint Pharmaceuticals Oculis AnaptysBio Fortrea Third Harmonic Bio (NASDAQ:THRD) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Do insiders and institutionals hold more shares of THRD or MDXG? 94.0% of Third Harmonic Bio shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 7.8% of Third Harmonic Bio shares are held by insiders. Comparatively, 1.7% of MiMedx Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor THRD or MDXG? In the previous week, MiMedx Group had 1 more articles in the media than Third Harmonic Bio. MarketBeat recorded 1 mentions for MiMedx Group and 0 mentions for Third Harmonic Bio. MiMedx Group's average media sentiment score of 0.83 beat Third Harmonic Bio's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the news media. Company Overall Sentiment Third Harmonic Bio Neutral MiMedx Group Positive Which has better valuation and earnings, THRD or MDXG? MiMedx Group has higher revenue and earnings than Third Harmonic Bio. Third Harmonic Bio is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThird Harmonic BioN/AN/A-$45.47M-$0.62-8.68MiMedx Group$348.88M2.87$42.42M$0.2132.25 Do analysts prefer THRD or MDXG? Third Harmonic Bio presently has a consensus target price of $5.00, suggesting a potential downside of 7.06%. MiMedx Group has a consensus target price of $12.00, suggesting a potential upside of 77.17%. Given MiMedx Group's stronger consensus rating and higher possible upside, analysts plainly believe MiMedx Group is more favorable than Third Harmonic Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Third Harmonic Bio 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00MiMedx Group 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is THRD or MDXG more profitable? MiMedx Group has a net margin of 8.84% compared to Third Harmonic Bio's net margin of 0.00%. MiMedx Group's return on equity of 23.03% beat Third Harmonic Bio's return on equity.Company Net Margins Return on Equity Return on Assets Third Harmonic BioN/A -19.27% -18.67% MiMedx Group 8.84%23.03%17.09% Which has more volatility and risk, THRD or MDXG? Third Harmonic Bio has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.73, suggesting that its share price is 73% more volatile than the S&P 500. SummaryMiMedx Group beats Third Harmonic Bio on 12 of the 15 factors compared between the two stocks. Get Third Harmonic Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricThird Harmonic BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.80M$3.42B$6.15B$10.77BDividend YieldN/A2.26%5.71%4.83%P/E Ratio-4.3723.3129.7228.55Price / SalesN/A271.94499.21189.70Price / CashN/A45.1236.6160.67Price / Book0.8510.4012.016.61Net Income-$45.47M-$52.62M$3.32B$276.82M Third Harmonic Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDThird Harmonic BioN/A$5.38flat$5.00-7.1%N/A$242.80MN/A-4.37N/AMDXGMiMedx Group3.1866 of 5 stars$6.58+1.1%$12.00+82.4%+18.1%$963.22M$348.88M31.33870Upcoming EarningsPGENPrecigen4.3477 of 5 stars$3.20-0.3%$8.25+157.8%+352.1%$956.49M$4.34M-7.62190RAPPRapport Therapeutics3.2471 of 5 stars$24.88-5.0%$35.33+42.0%+1.3%$955.88MN/A-9.95N/APositive NewsGap UpTNGXTango Therapeutics2.0955 of 5 stars$8.70+2.7%$10.50+20.7%+20.1%$942.37M$24.30M-6.5490Trending NewsAnalyst ForecastGap UpMNMDMind Medicine (MindMed)3.3071 of 5 stars$12.62+3.0%$27.83+120.5%+100.5%$932.08MN/A-8.2540Gap UpBGMBGM Group0.8429 of 5 stars$9.60+1.2%N/A+23.6%$922.64M$25.10M0.00298News CoverageAnalyst ForecastShort Interest ↑Gap UpEYPTEyepoint Pharmaceuticals2.2662 of 5 stars$13.16-1.3%$26.86+104.1%+15.5%$919.49M$51.90M-4.91120OCSOculis2.7931 of 5 stars$21.54+2.6%$41.00+90.3%+31.3%$916.90MN/A-8.072Short Interest ↑ANABAnaptysBio2.8588 of 5 stars$31.85-1.9%$52.00+63.3%-2.2%$908.78M$91.28M-7.11100Analyst ForecastFTREFortrea3.2504 of 5 stars$9.55-2.7%$12.17+27.4%-41.7%$891.66M$2.70B-0.8415,500 Related Companies and Tools Related Companies MiMedx Group Competitors Precigen Competitors Rapport Therapeutics Competitors Tango Therapeutics Competitors Mind Medicine (MindMed) Competitors BGM Group Competitors Eyepoint Pharmaceuticals Competitors Oculis Competitors AnaptysBio Competitors Fortrea Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
